Table 1 Study Design, Quality Score, and Demographic Data of Included Studies
From: Perioperative Dexmedetomidine for outpatient cataract surgery: a systematic review
Study | Quality Score | Na | ASAb | Age in Dexmedetomidine Group(s)c | Age in Other Group(s)c | ||
|---|---|---|---|---|---|---|---|
Abdalla [23] | 3 | 40 | – | 63 (11) | 60 (13) | ||
Alhashemi [12] | 4 | 44 | I-III | 61 (34–79) | 61 (40–75) | ||
Altiparmak [24] | 5 | 80 | II-III | 58 (5.7) | 57 (5.8) | ||
Apan [11] | 3 | 90 | I-III | 65.7 (11.3) | midazolam | 65.8 (11.8) | |
saline | 66.3 (9.8) | ||||||
Ayoglu [21] | 1 | 40 | I-II | 50–75 | 50–75 | ||
Dogan [13] | 4 | 80 | I-II | 50–70 | 50–70 | ||
Erdurmus [14] | 3 | 44 | – | 67.41 (9.83) | 69.46 (9.99) | ||
Ghodki [15] | 4 | 60 | I-II | 62.6 (6.5) | 61.4 (6.9) | ||
Kermany [10] | 1 | 100 | I-II | 50.26 (9.44) | 51.9 (10.2) | ||
Muttu [16] | 1 | 40 | – | Unknown | Unknown | ||
Na [17] | 1 | 31 | I-III | 60.8 (11.4) | 57.4 (13.4) | ||
Park [22] | 0 | 80 | I-III | 60–80 | 60–80 | ||
Virkilla [19] | 0 | 35 | I-III | 0.25 mcg/kgd | 69.0 (8.7) | 60.8 (12.2) | |
0.5 mcg/kg | 70.2 (3.3) | ||||||
0.75 mcg/kg | 67.8 (6.7) | ||||||
1.0 mcg/kg | 66.6 (15.0) | ||||||
1.5 mcg/kg | 71.4 (10.9) | ||||||
Virkilla [20] | 4 | 90 | I-III | 63.3 (11.2) | midazolam | 66.2 (9.5) | |
placebo | 66.6 (10.3) | ||||||
Yagan [18] | 3 | 60 | I-III | 68.6 (8.4) | 66.4 (6.3) | ||